Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Post by wildbird1on Sep 15, 2024 8:02am
441 Views
Post# 36224265

For the FDA BTD approval, SAFETY is a priority...

For the FDA BTD approval, SAFETY is a priority...On this board most of the time ,we talk about the high CR% of TLT-Ruvidar, and with good reasons, it is the best CR% of any treatments for incurable BCG resistant patients.
But! There is one very important feature of TLT-Ruvidar not discussed very often, and it is safety.

Safety a major win...
In this link(About FDA's speedy BTD approval)...The FDA’s Speedy Drug Approvals Are Safe: A Win-Win for Patients and Pharma Innovation - HBS Working Knowledge
It said....
'' If there are ways to accelerate the development of new medicines without compromising their safety, this would be a major win for patients as well as for manufacturers...Regulations in health care product market exist for a very good reason, we don't want drugs that are dangerous being released to the public''.
In Short...
For the FDA, safety is of the utmost importance when giving BTD approval.

TLT-Ruvidar is 100% safe.
Who would benefit the most from TLT-Ruvidar being 100% safe?
1) Patients...Patients will be more likely to accept a 100% safe treatment.
2) Doctors...Doctors will be more likely to recommend its patients a 100% safe treatment.
3) Private and government insurance programs. Insurance programs will love a 100% safe treatment.
Why?
Because side effects cost extra big money for insurance programs.
4) And that goes without saying, TLT and investors will benefit from a 100% safe treatments.
Note: No other FDA approved treatment for incurable BCG resistant patients is 100% safe.

How much$ is worth a BCG resistant treatment 100% safe and with the best CR%?
That is a very tough question...
Why?
Because TLT-Ruvidar is the first treatment for BCG resistant patients, that has both, the best CR% and is 100% safe.
Good luck if you want to place a $value on the above.

You have to love TLT-Ruvidar being 100% safe.


.
<< Previous
Bullboard Posts
Next >>